KEVIN KIM
HACKENSACK, NJ
Browse related groups: NJ GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$250.44
- Category: General Payments
- Program years: PY2023–2024
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $234.44 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $234.44 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $138.49 | 2 |
| ABBVIE INC. | $79.09 | 6 |
| Merck Sharp & Dohme Corporation | $16.86 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1113855176 | ABBVIE INC. | $8.56 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113855182 | ABBVIE INC. | $16.34 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113855188 | ABBVIE INC. | $16.31 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113855194 | ABBVIE INC. | $12.61 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113855200 | ABBVIE INC. | $13.09 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113855205 | ABBVIE INC. | $12.18 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116474227 | GlaxoSmithKline, LLC. | $16.06 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116646655 | GlaxoSmithKline, LLC. | $122.43 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141744731 | Merck Sharp & Dohme LLC | $16.86 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.